脱水氨可以通过抑制SP1/Hsp90ab1/COX-2信号通路来缓解原发性经期障碍
Daojuan Wang1, Zhengquan Zhu2, Juan Zhao3
1Department of Pain Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008 China; State Key Laboratory of Analytical Chemistry for Life Science and Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing 210008 China.
患有原发性经期障碍 (PD) 的女性的低水平与疼痛增加有关. 针对由SP1驱动的Hsp90ab1和COX-2通路,为缓解月经疼痛提供了一个新的治疗策略.
科学领域:
- 内分泌学 在内分泌学.
- 疼痛管理 疼痛管理
- 分子生物学分子生物学
背景情况:
- 众所周知,雄激素可以保护女性免受慢性疼痛.
- 雄激素及其机制在原发性更年障碍 (PD) 中的具体作用尚不清楚.
研究的目的:
- 调查雄激素的作用,并确定关键的分子途径,涉及到初级失经症.
- 探索潜在的治疗目标来管理PD.
主要方法:
- 对患有PD的女性血清丸激素水平的临床数据分析与对照.
- 利用 PD 的小鼠模型研究子宫基因表达和疼痛.
- 研究了脱水氨 (DHEA),凝丹胺素 (Hsp90ab1抑制剂) 和胺素 (SP1抑制剂) 的作用.
- 评估了Hsp90ab1过度表达对DHEA治疗效果的影响.
主要成果:
- 患有PD的女性的血清丸激素水平较低,与疼痛严重程度相反相关.
- 在PD小鼠模型中,子宫Hsp90ab1和COX-2被上调.
- DHEA治疗,Hsp90ab1抑制和SP1抑制可以缓解PD症状.
- SP1被确定为Hsp90ab1的转录驱动者,Hsp90ab1的过度表达逆转了DHEA的益处.
结论:
- 雄激素缺乏通过上调SP1介导的Hsp90ab1和COX-2表达来促进PD.
- 这条路径形成了一个关键循环,加剧了月经疼痛.
- 准SP1-Hsp90ab1-COX-2轴为PD提供了一个有希望的治疗途径.
更多相关视频
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
06:22Ex Vivo Method for Assessing the Mouse Reproductive Tract Spontaneous Motility and a MATLAB-based Uterus Motion Tracking Algorithm for Data Analysis
Published on: September 1, 2019
相关概念视频
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Internal Receptors
Analgesia and Pain Management
Drugs Affecting Neurotransmitter Synthesis
